UHE-103 / Therapeutics Inc 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
UHE-103 / Therapeutics Inc
NCT05363449: Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis

Completed
1
42
US
UHE-103 Cream, Naftin (naftifine hydrochloride) Cream
Therapeutics, Inc.
Tinea Cruris, Tinea Pedis
11/23
11/23

Download Options